1985
DOI: 10.1016/0163-7258(85)90068-3
|View full text |Cite
|
Sign up to set email alerts
|

The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

1990
1990
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(6 citation statements)
references
References 175 publications
0
6
0
Order By: Relevance
“…Since both cognate DNA damage and noncognate DNA damage enrich Pol IV at the replication fork in an SSB-dependent manner, our results suggest that any obstacles to processive replication may act as a molecular signal for the recruitment of Pol IV. To test this possibility, we treated cells with the ribonucleotide reductase (RNR) inhibitor hydroxyurea (HU) ( 40 ). RNR inhibition by HU depletes cellular deoxynucleoside triphosphate pools, ultimately leading to replication stalling and cell death ( 41 ).…”
Section: Resultsmentioning
confidence: 99%
“…Since both cognate DNA damage and noncognate DNA damage enrich Pol IV at the replication fork in an SSB-dependent manner, our results suggest that any obstacles to processive replication may act as a molecular signal for the recruitment of Pol IV. To test this possibility, we treated cells with the ribonucleotide reductase (RNR) inhibitor hydroxyurea (HU) ( 40 ). RNR inhibition by HU depletes cellular deoxynucleoside triphosphate pools, ultimately leading to replication stalling and cell death ( 41 ).…”
Section: Resultsmentioning
confidence: 99%
“…HU inhibits the activity of RNR by scavenging its free radical necessary for catalysis, and the reduced RNR activity leads to decreased concentration of dNTPs in the cell [35]. Here, wild type cells (MG1655) grown in glu-CAA-uri medium at 37°C, were treated with different concentrations of HU (2.5, 5 and 10 mM) to see if we could obtain a situation of reduced fork movement, but unchanged growth rate.…”
Section: Resultsmentioning
confidence: 99%
“…Common fragile sites are large genomic regions of 250 kb–1 Mb that are unstable under conditions that partially inhibit DNA replication (reviewed in [1]). Treatment with aphidicolin, which inhibits DNA polymerases [2], [3], or hydroxyurea, which inhibits ribonucleotide reductase and results in unbalanced nucleotide pools [4], both cause replication stress that induces instability at fragile sites. Several mechanisms have been proposed to explain why breaks form in human common fragile sites, including secondary structure formation within single-stranded DNA (ssDNA) at stalled replication forks [5], [6], paucity of replication origins [7], [8], replication fork pausing between early- and late-replicating regions [9], [10], and collision between RNA and DNA polymerases [11].…”
Section: Introductionmentioning
confidence: 99%